1:NORMAL EMBRYOLOGY AND DEVELOPMENT
1:ANATOMY
1:ANOMALIES
1:INFLAMMATORY AND RELATED DISEASES
2:Mammary Duct Ectasia
2:Mammary Fat Necrosis
2:Granulomatous Lobular Mastitis
3:Definition
3:Clinical Features
3:Pathology
3:Differential Diagnosis
2:Sclerosing Lymphocytic Lobulitis
3:Definition
3:Clinical Features
3:Pathology
3:Immunohistochemistry
3:Differential Diagnosis
1:BENIGN PROLIFERATIVE BREAST DISEASE
2:Fibroadenoma
3:Definition
3:Clinical Features
3:Pathology
3:Differential Diagnosis
2:Breast Adenoma
2:Fibrocystic Disease
3:Definition
3:Clinical Features
3:Pathology
3:Immunohistochemistry
3:Molecular Biology
3:Differential Diagnosis
2:Benign Lesions Closely Related to Fibrocystic Changes
3:Blunt Duct Adenosis
3:Sclerosing Adenosis
3:Microglandular Adenosis
3:Adenomyoepithelioma
3:Myofibroblastoma
3:Sclerosing Papillary Proliferations (Radial Scars, Complex Sclerosing Lesions)
3:Duct Adenoma
3:Intraductal Papilloma
2:Atypical Ductal Hyperplasia
3:Definition
3:Clinical Features
3:Pathology
3:Molecular Biology
3:Immunohistochemistry
3:Differential Diagnosis
1:BREAST CARCINOMA
2:General Comments
2:Breast Carcinoma Types
3:Ductal Carcinoma in Situ
4:definition
4:clinical features
4:histopathology
4:immunohistochemistry and molecular biology
3:Lobular Carcinoma in Situ
4:definition
4:clinical features
4:pathology
4:immunohistochemistry and molecular biology
3:Invasive Breast Carcinoma
4:invasive ductal carcinoma of no special type
5:Definition
5:Clinical Features
5:Pathology
5:Immunohistochemistry and Molecular Biology
4:invasive lobular carcinoma
5:Definition
5:Clinical Features
2:Grading of Breast Carcinoma: Modified Bloom-Richardson (MBR) Scheme(Table Captions)
5:Pathology
5:Immunohistochemistry and Molecular Biology
3:Mucinous Carcinoma
4:definition
4:clincial features
4:pathology
4:immunohistochemistry
3:Tubular and Cribriform Carcinoma
4:definition
4:clinical features
4:pathology
4:immunohistochemistry and molecular biology
3:Papillary Carcinoma
4:definition
4:clinical features
4:pathology
3:Metaplastic Carcinoma
3:Medullary Carcinoma
4:definition
4:clinical features
4:pathology
4:immunohistochemistry and molecular biology
3:Secretory Carcinoma
4:definition
4:clinical features
4:pathology
4:immunohistochemistry
3:Adenoid Cystic Carcinoma
4:definition
4:clinical features
4:pathology
4:immunohistochemistry
3:Miscellaneous Types or Variant Presentations of Breast Carcinoma
3:Inflammatory Carcinoma
3:Pagetâ€™s Disease
3:Occult Breast Carcinoma
2:New Approaches to Classifying Breast Carcinoma
2:Staging
2:Therapy and Related Pathologic Alterations
1:STROMAL AND VASCULAR TUMORS
2:Phyllodes Tumor
3:Definition
3:Clinical Features
3:Pathology
3:Differential Diagnosis
2:Angiosarcoma
3:Definition
3:Clinical Features
3:Differential DiagnosisPathology
3:Immunohistochemistry
1:OTHER PRIMARY TUMORS AND TUMOR-LIKE CONDITIONS
1:LYMPHOID TUMORS
1:PATTERNS OF METASTASES TO AND FROM BREAST CARCINOMA
1:BREAST DISEASES IN CHILDREN AND ADOLESCENTS
1:BREAST DISEASES IN MALES
1:PROGNOSTIC AND PREDICTIVE FACTORS IN BREAST CARCINOMA
2:Prognostic Factors for Predicting Local Recurrence
2:Molecular Prognostic Indicators
3:Proto-oncogene Expression
3:Tumor Suppressor Genes
2:Estrogen and Progesterone Receptors
2:Histologic Grading of Breast Carcinoma
2:Mitotic Counts in Breast Carcinoma(Table Captions)
2:Measures of Tumor Cell Proliferation Rate
3:Flow Cytometric Analysis
2:Sentinel Lymph Node Biopsy
3:Surgical Techniques
3:Current Studies in Breast Carcinoma Patients
3:Radioactivity
3:Specimen Handling
3:Frozen Sections of Sentinel Nodes
3:Pathology Report
2:Use of Prognostic Factors in Treatment Decisions
3:International Consensus Guidelines
3:Risk Categories
2:Risk Categories for Patients with Breast Cancer(Table Captions)
2:Treatment Modalities(Table Captions)
